César A Rodríguez Sánchez

6PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersExercise physiologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.

|Sep 05, 2024
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer.

Eduardo Terán, Rebeca Lozano, César A Rodríguez

|Jun 23, 2024
Exercise in cancer patients: assistance levels and referral pathways-a position statement from the Spanish Society of Medical Oncology.

Blanca Herrero López, Ana Cardeña-Gutiérrez, Ana Godoy Ortiz

|Feb 02, 2024
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.

Lucjan Wyrwicz, César A Rodríguez Sánchez, Pedro Sánchez-Rovira

|May 03, 2021
Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.

Laura Pedraza-Nieto, Mónica Beunza-Sola, César A Rodríguez

|Aug 29, 2017
Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.

Cesar A Rodriguez, Teresa Martin, Rebeca Lozano

Pageof 1

Frequent Collaborators

2 joint publications

Miguel Ángel Seguí Palmer

1 joint publications

Laura Pedraza-Nieto

1 joint publications

Mónica Beunza-Sola

1 joint publications

Esther Moreno